Latest News
Surgical Therapeutic Options in Duodenal GISTs Explored
The Future of Advanced Medical Imaging Explored in GIST
New GIST Trial Opens
Anlotinib Yields Promising Results in GIST Clinical Trial
An Interview With Sara Rothschild, Executive Director of the Life Raft Group
Exploring the Laparoendoscopic Approach to Manage GISTs
Small Bowel GIST Linked with Worse Outcomes Than Gastric GIST
Ripretinib May Lead to Clinical Benefits in Select Patients With GIST
New Study Suggests Expanded Genetic Testing for Patients With GIST
Latest Clinical Trials
Insights
How Can Adherence to Imatinib Therapy in Patients With GIST Be Improved?
To improve adherence to treatment regimens prescribed, we first need to understand the underlying concerns of patients.
The Multifaceted Challenges of Treating GIST in Pediatric Patients
There are a few major hurdles physicians have to navigate when treating pediatric patients with gastrointestinal stromal tumors.
Can Artificial Intelligence Be Used to Predict Malignant Potential in GIST?
Artificial intelligence has been shown to have good predictive value for the malignant potential of gastrointestinal stromal tumors.
Beyond Imatinib: Next-Generation TKIs for the Treatment of GIST
Recently developed TKIs such as ripretinib and avapritinib have the potential to change the treatment landscape of GIST.
Patient Perspectives
A GIST Patient’s Journey: A Quest to be Heard
When diagnosed with a gastrointestinal stromal tumor (GIST) or any rare disease, the patient usually sees a doctor specializing in the treatment of that disease. Unfortunately, I live on a rock in the middle of the ocean, which makes finding the right doctor especially difficult.
Help GIST Patients Find Their New Normal
Many cancer patients would disagree, but GIST cancer has been both the best and worst thing that has ever happened to me.
A Frontline View: A Clinical Trial For Pediatric and Wildtype (SDHA) GIST
Three years ago, I heard one of the many things a cancer patient does not want to hear, “You have new growths. You’ve relapsed.” It was the first time I cried because of my cancer diagnosis, reality finally hit, and I was devastated. Relapsing with pediatric and wildtype (SDHA) gastrointestinal stromal tumor (GIST) was hard…
GIST Features
New Chief Takes the Helm at the Life Raft Group as GIST Research Continues to Expand
The Life Raft Group, which advocates for people with gastrointestinal stromal tumor (GIST), has a new executive director: Sara Rothschild.
Using Deep Learning to Predict Risk in Gastrointestinal Stromal Tumors
Deep learning is now used to detect disease or abnormalities from x-ray images and classify them into several disease types or severities in radiology.
New Advances in the Radiomics of Gastrointestinal Stromal Tumors
It has been shown that radiomic features may be useful for predicting patient survival, treatment response, and metastatic potential of tumors.
Israel Emerges as Global Powerhouse in Rare Disease Research
When it comes to rare disorders, Israel—a New Jersey-sized nation of 9.3 million that’s made headlines this year for its highly successful coronavirus vaccination campaign—is clearly an emerging powerhouse.
Rare Care Podcast
Advocating for People With Gastrointestinal Stromal Tumor: An interview with Peter Knox, senior research director at the Life Raft Group
- Loading...
Loading...
Loading... 
Loading...